RIBOMIC

RIBOMIC enters license agreement with AJU Pharma for RBM-007 in age-related macular degeneration
Pharmaceutical Business Review
Wed, 03/18/20 - 10:17 am
RIBOMIC
AJU Pharm Co
Korea
RBM-007
age-related macular degeneration